Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

343536373839404142

UPDATE: EU drug watchdog approves AstraZeneca Covid prevention jab

24th Mar 2022 20:28

(Alliance News) - The EU's drug watchdog on Thursday recommended for approval AstraZeneca PLC's Covid-19 prevention cocktail, which can be used for patients with immune system problems or severe reactions to other coronavirus vaccines. Read More

TOP NEWS: EU drug watchdog approves AstraZeneca Covid prevention jab

24th Mar 2022 16:56

(Alliance News) - The EU's drug watchdog on Thursday recommended for approval AstraZeneca's Covid-19 prevention jab, which can be used for patients with immune system problems or severe reactions to normal vaccines. Read More

AstraZeneca's Imfinzi fails to meet endpoint in Phase 3 trial

24th Mar 2022 09:05

(Alliance News) - AstraZeneca PLC on Thursday said that a Phase 3 trial for its immunotherapy Imfinzi did not achieve its primary endpoint in the treatment of patients with locally advanced cervical cancer. Read More

UK dividends calendar - next 7 days

21st Mar 2022 15:48

Read More

AstraZeneca's Alexion to pay USD775 million in Ultomiris settlement

17th Mar 2022 09:01

(Alliance News) - AstraZeneca PLC on Thursday said its Alexion subsidiary has reached a settlement agreement with Roche Holding AG's Chugai Pharmaceutical Co Ltd resolving all patent disputes between the two related to rare blood disease drug Ultomiris. Read More

AstraZeneca, Merck & Co's Lynparza improves cancer survival rate

16th Mar 2022 18:21

(Alliance News) - AstraZeneca PLC and Merck & Co Inc on Wednesday said their jointly-developed Lynparza drug reduces the risk of death in a form of breast cancer. Read More

IN BRIEF: AstraZeneca's Lynparza approved in US as adjuvant treatment

11th Mar 2022 21:40

AstraZeneca PLC - Cambridge, England-based drugmaker - Says Lynparza treatment has been approved in the US for the adjuvant treatment of patients with germline BRCA-mutated HER2-negative high-risk early breast cancer, who have already been treated with chemotherapy either before or after surgery. Read More

Hutchmed receives USD15 million from AstraZeneca for Saffron progress

7th Mar 2022 10:04

(Alliance News) - Hutchmed (China) Ltd on Monday said it has received USD15 million from AstraZeneca PLC as start-up activities for Saffron commenced. Read More

LONDON BROKER RATINGS: UBS raises Pearson; BofA ups Croda to buy

7th Mar 2022 09:46

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday afternoon: Read More

Astra closes USD760 million human monoclonal antibody collaboration

1st Mar 2022 09:39

(Alliance News) - AstraZeneca PLC said on Tuesday its rare disease group has closed an exclusive global collaboration to develop and commercialise an investigational human monoclonal antibody. Read More

LONDON MARKET OPEN: Stocks lower; Reach sinks on inflation warning

1st Mar 2022 09:20

(Alliance News) - Stock prices in London opened lower on Tuesday amid rising concerns over Russia's attack on Ukraine. Read More

LONDON BROKER RATINGS: Stifel prefers AstraZeneca over GlaxoSmithKline

28th Feb 2022 09:51

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning: Read More

IN BRIEF: AstraZeneca Chair Leif Johansson to retire at 2023 AGM

22nd Feb 2022 14:20

AstraZeneca PLC - Cambridge, England-based pharmaceutical firm - Non-Executive Chair Leif Johansson will retire at Astra's annual general meeting in 2023. It will hold its AGM this year on April 29, and Johansson will stand for election for one more year. Johansson joined the Astra board in 2012, so he reached the normal term limit of nine years last year. However, he was asked to stay on to oversee Astra's acquisition of the US's Alexion Pharmaceuticals, which is now completed. Senior Independent Non-Executive Director Philip Broadley is leading the search for a new chair. Read More

LONDON MARKET CLOSE: Risk-off trade as Russia-Ukraine concerns persist

21st Feb 2022 17:02

(Alliance News) - Worries over Ukraine dominated once more at the start of the week, with the FTSE 100's morning gains giving way to risk-off trade in the afternoon on doubts over a summit between Russia and the US. Read More

LONDON MARKET MIDDAY: Stocks down as Russia pours cold water on summit

21st Feb 2022 12:14

(Alliance News) - Stock prices in London turned lower at midday on Monday after conflicting statements about plans for a US-Russia summit to discuss Ukraine, dousing an earlier wave of optimism. Read More

AstraZenca's Enhertu improves breast cancer survival outcomes

21st Feb 2022 10:16

(Alliance News) - AstraZeneca PLC said on Monday phase three trials for Enhertu showed positive outcomes in metastatic breast cancer patients and could "redefine how the disease is classified and treated". Read More

UK dividends calendar - next 7 days

17th Feb 2022 16:07

Read More

Astra and Sanofi's nirsevimab granted accelerated EU assessment

17th Feb 2022 14:39

(Alliance News) - AstraZeneca PLC on Thursday said nirsevimab, which is being developed in collaboration with Sanofi SA, has been accepted for accelerated review by the European Medicines Agency. Read More

LONDON BROKER RATINGS: Goldman ups Glencore price target, cuts Pearson

16th Feb 2022 09:31

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday: Read More

TOP NEWS: AstraZeneca receives approval by EU for biologic Saphnelo

16th Feb 2022 09:06

(Alliance News) - AstraZeneca PLC on Wednesday said the EU approved its biologic Saphnelo for the treatment of moderate to severe systemic lupus erythematosus, an autoimmune condition. Read More

343536373839404142
FTSE 100 Latest
Value8,774.65
Change-17.15